Mining Engineer Co-op Intern - Summer 2027
About the job
- Candidates must be junior level or above by May 2027 and pursuing a bachelor's degree in Mining Engineering.
- Candidates must have a cumulative GPA of 2.75 or higher.
- Candidates must be able to function in an industrial chemical and mining environment.
- Candidates must have reliable transportation and a valid driver's license.
- Candidates must be able to work full time while remaining a student in good standing during the co-op/internship.
- Candidates must successfully complete post-offer/pre-placement drug and alcohol screening, a background check, a physical examination, and a functional capacity examination.
- Candidates must have basic computer skills.
- Candidates must be able to work in a team environment.
- Candidates must safely perform the essential job functions without posing a direct threat to their own safety or the safety of others.
- Candidates must be able to occasionally lift approximately 0-25 pounds.
- Candidates must be able to climb stairs and work at various heights.
- Candidates must be able to distinguish varying or specific colors, patterns, or materials.
- Candidates must be able to hear with or without correction.
- Candidates must be able to read, write, and understand basic English.
- Candidates must be able to see with or without correction.
- Candidates must be able to use fine hand motor skills.
- Candidates must be able to wear a respirator.
- Candidates must be authorized to work in the United States.
- Complete assignments involving mine planning, operations optimization, quality control, mapping, and other aspects of working at a mining site.
- Communicate with management, plant operators, engineers from various disciplines, tradespersons, and contractors.
- Participate in department meetings and meetings specific to the project assignment.
- Adhere to Mosaic's mission, guiding principles, priorities, and key competencies.
- One to two years of experience volunteering, working with student or school organizations, or working experience.
- Previous internship or co-op experience.
- Familiarity with an industrial environment.
- Effective verbal communication skills.
About the company
Mosaic supplies crop nutrients and fertilizers to farmers worldwide. Its products are formulated to meet crop nutrient needs, helping fields grow with better yields by delivering essential nutrients through fertilizers and other soil amendments. The company operates in North and South America, employs over 13,000 people across six countries, and distributes products globally. Mosaic differentiates itself by focusing on sustainability and corporate citizenship, seeking to maximize efficiency and minimize environmental impact while maintaining transparent, ethical practices and strong ESG performance to build trust with customers and communities. The company’s goal is to support global food production by providing reliable, responsible fertilizer solutions that boost productivity while reducing environmental footprint.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Tampa, Florida
Founded
2004
Get referred to Mosaic
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q2 2026 adjusted EBITDA reached $407 million, beating catastrophe narratives despite losses.
- Analysts still target $27 to $32, backing margin recovery into 2027.
- Lower capex and working-capital release can lift cash flow as sulfur normalizes.
What critics are saying
- Louisiana idled phosphate plants and 206 layoffs by October 10 expose operational fragility.
- Q2 phosphate margins turned negative from sulfur and ammonia costs, crushing earnings.
- If sulfur stays scarce into 2027, Mosaic loses volume, cash, and bargaining power.
What makes Mosaic unique
- Mosaic controls phosphate and potash assets across Americas, protecting supply in fertilizer shortages.
- Renuvis Enzara, launched August 17, 2026, expands Mosaic Biosciences beyond commodity fertilizers.
- Its debt tender and redemption program cut near-term maturities, strengthening financing flexibility.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Sick Leave
Health Savings Account/Flexible Spending Account
Tuition Reimbursement
Company News
The Mosaic Company announces Executive Leadership changes. Sep. 25, 2026 The Mosaic Company united states follow. The Mosaic Company (NYSE: MOS) announced that Karen Swager, Executive Vice President - Operations, plans to retire. Walt Precourt, Senior Vice President and Chief Administrative Officer (CAO) will assume the role of Executive Vice President - Operations effective December 1. Ms. Swager will continue to serve as a senior advisor until her retirement in the second quarter of 2027. Mr. Precourt joined Mosaic in 2009 and has led the company's phosphate and potash businesses, as well as its Environmental, Health and Safety (EHS) and Strategy work. In his current role as CAO, Mr. Precourt leads the company's Procurement, Human Resources, Public Affairs and Global Business Services groups. He has been a member of the company's Executive Leadership Team since 2014. "I am pleased that Walt will lead our operations as we continue to navigate challenging business conditions, especially in phosphate," said President and CEO Bruce Bodine. "Walt's thoughtful leadership and thorough knowledge of Mosaic's complex operations are well known and widely appreciated across the company. I have every confidence that he will build on Karen's legacy of steady improvements at our operating sites." In addition to leading global operations, Mr. Precourt will lead the company's EHS function. He will continue to be based in Mosaic's Tampa executive office. Ms. Swager's career at Mosaic and predecessor companies spans over three decades. She served as General Manager of several Mosaic operating facilities, led the potash business and the company's supply chain, and assumed the role of EVP - Operations in 2023. "Karen has had a remarkable career at Mosaic," Mr. Bodine said. "Her legacy of leading with heart and courage, and of driving safety, efficiency and value, will be forever etched in our company's history. I know that everyone at Mosaic joins me in wishing her all the best in retirement."
Walt Precourt Promoted To Mosaic Company's Exec VP/Operations | Published on: Sep 23, 2026
Mosaic Biosciences, a unit of The Mosaic Company, launched Renuvis Enzara on 17 August, an enzyme-based treatment designed to accelerate crop residue breakdown after harvest. The launch came less than two weeks after Mosaic reported a second-quarter net loss of $273 million, reversing the $411 million profit from the same period in 2025. The enzyme technology works in cold soil down to 32 degrees Fahrenheit, targeting structural fibres in crop residue to help farmers achieve plant-ready fields faster. Mosaic's second-quarter revenue reached $2.8 billion, but the company posted a $36 million operating loss. The phosphate segment recorded a $104 million operating loss, whilst Mosaic Fertilizantes swung to a $41 million loss from $109 million in earnings year-over-year.
Over 200 Mosaic employees laid off at two facilities amid sulfur supply shortage. DONALDSONVILLE - The Mosaic Company will lay off over 200 employees at two of its Louisiana facilities due to ongoing sulfur supply constraints affecting phosphate fertilizer pro...
Mosaic stock rises as analysts back margin recovery story. ELLIS HOBBS - UPDATED AUG. 21, 2026, 4:37 PM ET Mosaic Company (The) stocks have been trading up by 4.63 percent amid upbeat sentiment on stronger fertilizer demand and pricing. What traders need to know. * RBC Capital Markets reaffirmed an Outperform on Mosaic Company (The) with a $27 target, seeing a cyclical margin recovery ahead while free cash flow improves from lower capex and a working-capital tailwind into 2027. * BNP Paribas lifted its MOS price target to $32 and kept an Outperform rating, with overall analyst opinion overweight and clustered around a $27 average target. * Mizuho nudged its MOS target to $25 but stayed Neutral, showing improved yet still cautious sentiment on the fertilizer name. * Recent Q2 2026 adjusted EPS of $0.13 came in just above the $0.12 consensus, a modest beat in a weak pricing backdrop. * Management launched and then completed up to $1.4B of note repurchases and refinancings and rolled out Renuvis Enzara via Mosaic Biosciences, combining balance sheet cleanup with product innovation. Weekly Update Aug 17 - Aug 21, 2026: On Friday, August 21, 2026 Mosaic Company (The) stock [NYSE: MOS] is trending up by 4.63%! Discover the key drivers behind this movement as well as its expert analysis in the detailed breakdown below. Materials industry expert: Analyst sentiment - positive Mosaic sits in the lower half of the global fertilizer cost curve, but current fundamentals are stressed. Q2 revenue annualizes to roughly flat versus 2024, with gross margin near 11% and negative EBIT, ROE, and net margin (LTM profit margin about -5%). Working-capital build and $317m capex drove negative Q2 FCF of ~$153m, leaving cash only $294m versus $1.44bn current debt and a thin 1.3x current ratio. The offset is low equity valuation: ~0.6x book and ~0.6x sales. Price action shows a sharp, high-volume momentum reversal: the stock moved from ~21.2 to 24.4 in five sessions, breaking multiple prior resistance bands and establishing a new short-term uptrend. Consecutive higher highs and higher lows on both daily and intraday 5-minute candles confirm aggressive dip-buying, especially on pullbacks near 22-23. The key actionable level is $23.00: above it, long bias with stops near 22.30; a decisive breakdown below 23.00 would signal exhaustion and a likely retest of the 21-22 zone. Fundamental and technical catalysts are turning favorable relative to Materials and Ag peers. Street targets cluster around $27-32 with predominantly Outperform ratings, reflecting confidence in phosphate margin recovery into 2027, tighter sulfur, and Mosaic's capex discipline plus debt-tender program de-risking the balance sheet. New biosciences products add optionality but are not thesis-critical. I see upside to $27 over 6-12 months, with support at $22 and strong resistance near $27-28. Quick financial overview. Mosaic Company (The) is trading in the mid-$20s, with weekly data showing a steady climb from roughly $21 to about $24. The stock's move from a $21.23 open early in the week toward a $24.43 close reflects a firm short-term uptrend. Intraday, MOS showed a controlled grind higher from the low $23s to the mid-$24s, with minor pullbacks being bought. For short-term traders, that intraday pattern signals demand on dips rather than panic selling. On the fundamentals, Mosaic Company (The) generated about $12.1B in trailing revenue, but margins are thin, with gross margin near 11% and recent net margins negative. Q2 2026 results showed revenue around $2.82B, a small gross profit and an operating loss, highlighting how tough fertilizer pricing has been. Still, adjusted EPS of $0.13 slightly topped expectations, which helps explain why analysts see MOS as an early-stage recovery rather than a broken story. Valuation leans supportive. With price-to-sales around 0.58 and price-to-book near 0.62, MOS trades at a discount to its asset base, typical for a cyclical trough. Balance sheet strength is reasonable, with total debt-to-equity at 0.54 and interest coverage of 6.3, and recent $1.4B note tenders further reduce near- and medium-term maturity risk. Cash flow is choppy, with recent free cash flow negative, but the company is targeting lower capex and an H2 working-capital reversal. A roughly 3.8% dividend yield adds carry for swing traders willing to sit through volatility. Conclusion. Mosaic Company (The) now sits at an interesting crossroads for active traders. The tape shows MOS pushing higher on the week, supported by a solid intraday uptrend and dip-buying behavior around the low $24s. At the same time, the financials confirm this is still a margin-compressed, cyclical name, not a clean growth story. That mix of improving price action against still-messy earnings is exactly where short-term setups can be most powerful. Street support adds fuel. RBC's Outperform call with a $27 target, backed by a margin recovery view into 2027, aligns with BNP Paribas' more aggressive $32 target and an overweight consensus around $27. The modest Q2 EPS beat, the $1.4B debt tender program, and the Renuvis Enzara launch all point to a management team working both the balance sheet and the product side. Yet negative recent net income and volatile free cash flow underline that MOS will not move in a straight line. For traders, MOS is a classic cyclical rebound candidate: cheap on sales and book, improving technically, but still hostage to fertilizer pricing and phosphate margins. That argues for trading plans with clear levels rather than blind conviction. This is exactly where discipline matters: chasing green candles in a choppy, cyclical name can be dangerous, no matter how compelling the narrative looks. As millionaire penny stock trader and teacher Tim Sykes, says, "There is always another play around the corner; don't chase just because you feel FOMO.". As I tell my students, "The edge in names like MOS comes from respecting the volatility, trading the levels, and letting the market confirm the recovery before you size up." This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Its content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to Millionaire Media, LLC. for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize its news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities. Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles: Once you've got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market's twists and turns. Dig into StocksToTrade's watchlists here: One-of-a-kind AI play revealed. If you'd put $2,000 into Nvidia back in 2020, you'd be sitting on more than $30,000 today. The stock's been an absolute monster... But if you think you missed the boat, then you need to see this urgent message TODAY. Because not only am I revealing why the REAL AI boom is only just getting started... I'm also going to show you my top AI recommendation that's been CRUSHING it in this market. It has nothing to do with Nvidia... or Meta... or OpenAI... or anything else you're probably thinking. It's a unique AI play I'm certain you're not hearing from anyone else... One that could give you the chance to target an entire YEAR of peak Nvidia potential... In just one day. How much has this post helped you? (0 votes, average: 0 out of 5)